Home >> Marketplace Directory >> HBV quantitative test, 4/17

HBV quantitative test, 4/17

image_pdfCreate PDF

 

April 2017—Quest Diagnostics launched a test service that aims to help physicians evaluate a patient’s response to drug therapies used to treat infection with the hepatitis B virus. The HBsAg qualitative test is used to aid in diagnosis of patients with HBV. The new quantitative test service measures the quantity, not just the presence, of viral antigen in blood to help determine if the immune system of an individual infected with HBV is responding to treatment. With this insight, according to a company statement, physicians are better positioned to monitor response to antiviral medications, and it may enable them to modify or adjust treatment to help minimize the likelihood of progression and reactivation.

Quest Diagnostics, 973-520-2700

CAP TODAY
X